2024 BIO Asia-Taiwan: NCHU Teams Up with Corporate Members to Showcase Outstanding Achievements
2024-07-30
秘書室
Unit秘書室
321
Source: NCHU Academia-Industry Collaboration Center
The most iconic biotechnology industry event in Asia, the "2024 BIO Asia-Taiwan," will be held from July 26 to 29 at the Taipei Nangang Exhibition Center Hall 1. National Chung Hsing University (NCHU), in collaboration with its internal research teams and enterprise members of its research industrialization platform, will showcase numerous technological achievements and industry highlights, garnering significant attention.
This year's theme, "Global View Asian Touch," will introduce new forums on innovative technologies, investment summits, and regional cooperation. The event will highlight Taiwan's expanding digital advantages in the biomedical field and focus on the latest developments in biotechnology, pharmaceuticals, medical devices, precision medicine, AI applications, ICT, IoT, and emerging medical investment opportunities. NCHU's research industrialization platform has meticulously integrated the university's biotech R&D resources for this biotech exhibition, leveraging the clustering effect of industry alliances to effectively connect industrial strengths, showcasing outstanding innovative achievements, and actively promoting the expansion of technology, capabilities, and products into global markets.
NCHU's exhibited research teams include Professor Kun-Lin Chen's team, which presents a magneto-optical immunoassay technique. This technique combines magnetic materials and optical technology to enhance the sensitivity of detecting target substances in samples at extremely low concentrations, demonstrating significant potential in biomedical detection. Additionally, Professor Chien-Cheng Lai's team has developed multi-omics strategies for food adulteration, origin, and source identification. By integrating data from different levels (e.g., genes, proteins, metabolites), they perform fusion analysis that not only improves the accuracy of food detection but also provides strong support for food safety and quality control.
The innovation team Xingyou Technology developed the STARBIA201 body composition analyzer, which uses rigorous scientific validation and data analysis to provide more precise and valuable measurement data for middle-aged and elderly people, benefiting national health management. The Aimia team uses AIMIA's spectral imaging processing and analysis system, achieving precise agricultural management through innovative image processing technology and AI, optimizing irrigation and other cultivation measures, effectively saving resources, and significantly reducing carbon emissions, promoting efficient and environmentally friendly agricultural production. Additionally, Gradio Company, Anter Environmental Technology Co., Ltd., and Taita Technology teams will also showcase their outstanding R&D achievements and contributions in pest control and the food industry. The general stem cell company, founded by Professor Hong-Lin Su from NCHU, developed the PCP (Peripheral Blood Cell Purification) mononuclear cell purification technology, an exclusive patented technology. This technique concentrates and purifies autologous peripheral blood mononuclear cells into M macrophages with anti-inflammatory and tissue repair functions, achieving cell therapy effects and significantly alleviating patient pain and restoring motor functions in clinical trials for degenerative arthritis. Incubated companies Yushin Medical Research and Hugel Biomedical's R&D achievements can serve as a foundation for future academic-industrial cooperation. Research platform members Taichung Veterans General Hospital, Changhua Christian Hospital, Da Nature Biotech, and Taimao Kwantong will also showcase their R&D achievements.
The most iconic biotechnology industry event in Asia, the "2024 BIO Asia-Taiwan," will be held from July 26 to 29 at the Taipei Nangang Exhibition Center Hall 1. National Chung Hsing University (NCHU), in collaboration with its internal research teams and enterprise members of its research industrialization platform, will showcase numerous technological achievements and industry highlights, garnering significant attention.
This year's theme, "Global View Asian Touch," will introduce new forums on innovative technologies, investment summits, and regional cooperation. The event will highlight Taiwan's expanding digital advantages in the biomedical field and focus on the latest developments in biotechnology, pharmaceuticals, medical devices, precision medicine, AI applications, ICT, IoT, and emerging medical investment opportunities. NCHU's research industrialization platform has meticulously integrated the university's biotech R&D resources for this biotech exhibition, leveraging the clustering effect of industry alliances to effectively connect industrial strengths, showcasing outstanding innovative achievements, and actively promoting the expansion of technology, capabilities, and products into global markets.
NCHU's exhibited research teams include Professor Kun-Lin Chen's team, which presents a magneto-optical immunoassay technique. This technique combines magnetic materials and optical technology to enhance the sensitivity of detecting target substances in samples at extremely low concentrations, demonstrating significant potential in biomedical detection. Additionally, Professor Chien-Cheng Lai's team has developed multi-omics strategies for food adulteration, origin, and source identification. By integrating data from different levels (e.g., genes, proteins, metabolites), they perform fusion analysis that not only improves the accuracy of food detection but also provides strong support for food safety and quality control.
The innovation team Xingyou Technology developed the STARBIA201 body composition analyzer, which uses rigorous scientific validation and data analysis to provide more precise and valuable measurement data for middle-aged and elderly people, benefiting national health management. The Aimia team uses AIMIA's spectral imaging processing and analysis system, achieving precise agricultural management through innovative image processing technology and AI, optimizing irrigation and other cultivation measures, effectively saving resources, and significantly reducing carbon emissions, promoting efficient and environmentally friendly agricultural production. Additionally, Gradio Company, Anter Environmental Technology Co., Ltd., and Taita Technology teams will also showcase their outstanding R&D achievements and contributions in pest control and the food industry. The general stem cell company, founded by Professor Hong-Lin Su from NCHU, developed the PCP (Peripheral Blood Cell Purification) mononuclear cell purification technology, an exclusive patented technology. This technique concentrates and purifies autologous peripheral blood mononuclear cells into M macrophages with anti-inflammatory and tissue repair functions, achieving cell therapy effects and significantly alleviating patient pain and restoring motor functions in clinical trials for degenerative arthritis. Incubated companies Yushin Medical Research and Hugel Biomedical's R&D achievements can serve as a foundation for future academic-industrial cooperation. Research platform members Taichung Veterans General Hospital, Changhua Christian Hospital, Da Nature Biotech, and Taimao Kwantong will also showcase their R&D achievements.
